Understanding Nemaline Myopathy Over Time (Spain)
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or suspected diagnosis of nemaline myopathy based on genetic testing or a muscle biopsy.
- Genetic mutation, if known, is in one of the following genes: ACTA1, NEB, TPM2, TPM3, KBTBD13, CFL2, KLHL40, KLHL41, LMOD3, MYPN, TNNT1, or TNNT3.
- You (or your legal guardian) must sign a consent form agreeing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with LAMA2-related muscular dystrophy over time to better understand the condition. It may help with future treatments by learning more about how the disease progresses.
This study tracks the health of people with nemaline myopathy over time to learn more about how the condition progresses. By joining, you help researchers understand the disease better, which may support future care and treatment development.
This study creates a network to gather information about people with nemaline myopathy, a genetic muscle disorder. It aims to improve understanding and support for future research and care.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This study follows people with a rare genetic muscle condition called TNNT1 myopathy over time. Researchers will track how the disease progresses to better understand it and help plan future treatments.
This study follows children with LAMA2-related muscular dystrophy to learn how the condition changes over time. It does not test a new treatment, but helps researchers understand the disease better.
Hear when a new Nemaline Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.